Estudo randomizado | Ceftolozano/tazobactam com metronidazol vs. meropeném em pacientes com infecções intra-abdominais complicadas. 22 Ago, 2022 | 16:26h A Phase 3, Multicenter, Double-blind, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Ceftolozane/Tazobactam Plus Metronidazole Versus Meropenem in Chinese Participants With Complicated Intra-abdominal Infections – International Journal of Infectious Diseases